SCHEMBL574228

SCHEMBL574228

CCCC(CCC)Nc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
LMNA P02545 3/20 0.69
KDM4E B2RXH2 2/20 0.69
USP2 O75604 2/20 0.69
HPGD P15428 2/20 0.69
HIF1A Q16665 2/20 0.69
HSD17B10 Q99714 2/20 0.69
CA2 P00918 2/20 0.69
TSHR P16473 1/20 0.69
BLM P54132 1/20 0.69
SLC12A2 P55011 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69
AQP1 P29972 1/20 0.52
SLC6A4 P31645 1/20 0.51
PTGS2 P35354 14/20 0.50
CA1 P00915 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11841124 0.84 KDM4E (0.88) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL10224099 0.83 KDM4E (0.80) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL11795232 0.83 KDM4E (0.62) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL11784490 0.82 ALDH1A1 (0.74) ALDH1A1LMNAKDM4EUSP2HPGD
Bumetanide SCHEMBL4425232 0.82 KDM4E (1.00) ALDH1A1LMNAKDM4EUSP2HPGD
Bumetanide SCHEMBL27525 0.82 KDM4E (1.00) ALDH1A1LMNAKDM4EUSP2HPGD
Bumetanide SCHEMBL29388271 0.82 KDM4E (1.00) ALDH1A1LMNAKDM4EUSP2HPGD
Bumetanide SCHEMBL23455698 0.81 KDM4E (0.98) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL11840406 0.81 KDM4E (0.94) ALDH1A1LMNAKDM4EUSP2HPGD
Bumetanide SCHEMBL251062 0.81 KDM4E (0.98) ALDH1A1LMNAKDM4EUSP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed